// App-Quantinova.ai

OP0148 (2018) : A validation of the 2017 eular/acr idiopathic inflammatory myopathies classification criteria in an expert-defined single-centre ten year incident cohort

Researchers

Presenter

  • M.J.S Parker

Principal Investigators

  • A. Oldroyd

  • M.E. Roberts

  • R.G. Cooper

  • J.B. Lilleker

  • A.L. Herrick

  • H. Chinoy

Medical Centers

  • Rheumatology Department, Salford Royal NHS Foundation Trust, Salford, United Kingdom

  • Rheumatology Department, Royal Prince Alfred Hospital, Sydney, Australia

  • Centre for Musculoskeletal Research, University of Manchester, Manchester, United Kingdom

  • 2Greater Manchester Neurosciences Centre, Salford Royal NHS Foundation Trust Salford United Kingdom

  • MRC/ARUK Centre for Integrated Research into Musculoskeletal Ageing, University of Liverpool, Liverpool, United Kingdom

Locations

  • United Kingdom

  • Australia

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Idiopathic inflammatory myopathies

Biomarkers

  • Albumin/creatinine

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved